DataRiver received funding for the European CCE-DART project (, funded by the H2020 Innovation Program ( The project aims to improve clinical trial design in Precision Oncology by incorporating a range of digital tools and statistical methods that ultimately ensure greater efficiency in the development and approval of new drugs.
In collaboration with the Vall d’Hebron Institute of Oncology (VHIO), the IRCCS National Cancer Institute (INT) Foundation and Cancer Core Europe (CCE) research partners, DataRiver will develop innovative digital tools to enhance patient engagement, support of the patient and the participation of the patient clinical trials.
The CCE-DART digital tools will allow to collect electronic informed consent in clinical trials and will allow potential trial participants and their caregivers to share information, documents, multimedia content, through secure two-way communication between patients and medical staff.